| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1473-3099(10)70194-8 |
| P698 | PubMed publication ID | 20961813 |
| P50 | author | Tom Solomon | Q18640365 |
| P2093 | author name string | David Perera | |
| Mary Jane Cardosa | |||
| Penny Lewthwaite | |||
| Peter McMinn | |||
| Mong How Ooi | |||
| P2860 | cites work | Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge | Q57101093 |
| Epidemics to eradication: the modern history of poliomyelitis | Q21245132 | ||
| DNA vaccine constructs against enterovirus 71 elicit immune response in mice | Q21245503 | ||
| Change of major genotype of enterovirus 71 in outbreaks of hand-foot-and-mouth disease in Taiwan between 1998 and 2000. | Q24531999 | ||
| Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People's Republic of China | Q24535192 | ||
| Comparison of the mutation rates of human influenza A and B viruses | Q24542982 | ||
| Pathologic Studies of Fatal Cases in Outbreak of Hand, Foot, and Mouth Disease, Taiwan | Q27487789 | ||
| Identification and validation of clinical predictors for the risk of neurological involvement in children with hand, foot, and mouth disease in Sarawak | Q27487876 | ||
| Scavenger receptor B2 is a cellular receptor for enterovirus 71 | Q28249350 | ||
| Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore | Q30233446 | ||
| Adenovirus type 21-associated acute flaccid paralysis during an outbreak of hand-foot-and-mouth disease in Sarawak, Malaysia | Q57105201 | ||
| The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management | Q57105763 | ||
| Genetic analysis of the VP1 region of Human enterovirus 71 strains isolated in Korea during 2000 | Q57214674 | ||
| Monoplegia caused by Enterovirus 71: an outbreak in Hong Kong | Q68972424 | ||
| Experimental neurogenic pulmonary edema. Part 1: The role of systemic hypertension | Q70766769 | ||
| Virological diagnosis of enterovirus type 71 infections: Experiences gained during an epidemic of acute CNS diseases in Hungary in 1978 | Q72939040 | ||
| Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease | Q73198212 | ||
| Poliomyelitis. 16. A study of pulmonary edema | Q74699232 | ||
| Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides | Q79557916 | ||
| Molecular epidemiology of enterovirus 71 infection in the Western Pacific Region | Q79850539 | ||
| Outcome of enterovirus 71 infections with or without stage-based management: 1998 to 2002 | Q79892365 | ||
| Genetic and antigenic analyses of enterovirus 71 isolates in Taiwan during 1998-2005 | Q80290931 | ||
| Genetic analysis of the VP1 region of enterovirus 71 reveals the emergence of genotype A in central China in 2008 | Q83816420 | ||
| Oral immunization of mice using transgenic tomato fruit expressing VP1 protein from enterovirus 71 | Q95821973 | ||
| Sentinel surveillance for human enterovirus 71 in Sarawak, Malaysia: lessons from the first 7 years | Q33249309 | ||
| Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient | Q33678253 | ||
| Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene | Q33725572 | ||
| An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. | Q33875086 | ||
| Neurologic complications in children with enterovirus 71 infection | Q33875092 | ||
| An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China | Q33911890 | ||
| Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. | Q33932759 | ||
| Clinical features, diagnosis, and management of enterovirus 71. | Q34144978 | ||
| Molecular Epidemiology of Human Enterovirus 71 Strains and Recent Outbreaks in the Asia-Pacific Region: Comparative Analysis of the VP1 and VP4 Genes | Q34215993 | ||
| Frequent importation of enterovirus 71 from surrounding countries into the local community of Yamagata, Japan, between 1998 and 2003. | Q34231826 | ||
| Frequency and dynamics of recombination within different species of human enteroviruses | Q34232997 | ||
| An overview of the evolution of enterovirus 71 and its clinical and public health significance | Q34635602 | ||
| Outbreaks of hand, foot, and mouth disease by enterovirus 71. High incidence of complication disorders of central nervous system | Q35114725 | ||
| Complete genomic sequencing shows that polioviruses and members of human enterovirus species C are closely related in the noncapsid coding region | Q35182328 | ||
| Cardiac complications of enterovirus rhombencephalitis | Q35279032 | ||
| A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection | Q35702513 | ||
| Flavivirus encephalitis. | Q35842969 | ||
| Recombinant human enterovirus 71 in hand, foot and mouth disease patients. | Q35873152 | ||
| An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys. | Q35948053 | ||
| Retrograde axonal transport: a major transmission route of enterovirus 71 in mice | Q35948100 | ||
| Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005. | Q36034012 | ||
| Basic rationale, current methods and future directions for molecular typing of human enterovirus | Q36874351 | ||
| Molecular epidemiology of human enterovirus 71 in the United Kingdom from 1998 to 2006. | Q36933517 | ||
| Epidemiology of enterovirus 71 in the Netherlands, 1963 to 2008. | Q37333587 | ||
| Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells | Q37362417 | ||
| Reemergence of enterovirus 71 in 2008 in taiwan: dynamics of genetic and antigenic evolution from 1998 to 2008. | Q37410530 | ||
| Development of enterovirus 71 vaccines. | Q37682898 | ||
| EV71: an emerging infectious disease vaccine target in the Far East? | Q37715371 | ||
| Frequency, viral loads, and serotype identification of enterovirus infections in Scottish blood donors. | Q38464819 | ||
| Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia | Q39606586 | ||
| Molecular epidemiology of enterovirus 71 over two decades in an Australian urban community. | Q39740071 | ||
| Enterovirus 71 infection of human dendritic cells | Q39825846 | ||
| Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. | Q39835244 | ||
| Enterovirus 71 outbreak, Brunei | Q39900119 | ||
| Epidemiology of enterovirus types causing neurological disease in Austria 1999-2007: detection of clusters of echovirus 30 and enterovirus 71 and analysis of prevalent genotypes | Q39901746 | ||
| Epidemic of Hand, Foot and Mouth Disease Associated with Enterovirus 71 Infection | Q40123768 | ||
| Epidemiologic features of hand-foot-mouth disease and herpangina caused by enterovirus 71 in Taiwan, 1998-2005. | Q40187425 | ||
| Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria | Q40272154 | ||
| Human enterovirus 71 disease in Sarawak, Malaysia: a prospective clinical, virological, and molecular epidemiological study. | Q40458463 | ||
| Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan. | Q40542265 | ||
| A murine oral enterovirus 71 infection model with central nervous system involvement | Q40600130 | ||
| Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group | Q40614108 | ||
| Isolation of subgenus B adenovirus during a fatal outbreak of enterovirus 71-associated hand, foot, and mouth disease in Sibu, Sarawak | Q40632168 | ||
| Genetic analysis of enterovirus 71 isolated from fatal and non-fatal cases of hand, foot and mouth disease during an epidemic in Taiwan, 1998. | Q40858986 | ||
| Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus | Q41261599 | ||
| The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways | Q42524022 | ||
| A preliminary neuropathological study of Japanese encephalitis in humans and a mouse model | Q43000958 | ||
| An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. | Q43408886 | ||
| An epidemic of enterovirus 71 infection among HIV-1-infected orphans in Nairobi. | Q43605729 | ||
| Protection of neonatal mice from lethal enterovirus 71 infection by maternal immunization with attenuated Salmonella enterica serovar Typhimurium expressing VP1 of enterovirus 71. | Q43914758 | ||
| Cardiopulmonary manifestations of fulminant enterovirus 71 infection | Q44119375 | ||
| Letter: New enterovirus type associated with epidemic of aseptic meningitis and-or hand, foot, and mouth disease | Q44158964 | ||
| Incidence and case-fatality rates resulting from the 1998 enterovirus 71 outbreak in Taiwan | Q44264114 | ||
| Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system | Q44285689 | ||
| Pulmonary edema of enterovirus 71 encephalomyelitis is associated with left ventricular failure: implications for treatment | Q44357592 | ||
| Neurogenic pulmonary edema in enterovirus 71 encephalitis is not uniformly fatal but causes severe morbidity in survivors | Q44494583 | ||
| Outbreak of severe neurologic involvement associated with Enterovirus 71 infection | Q44881432 | ||
| Enterovirus 71 infections at a Canadian center | Q44936587 | ||
| Acute chemokine response in the blood and cerebrospinal fluid of children with enterovirus 71-associated brainstem encephalitis | Q44951011 | ||
| Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge | Q45396589 | ||
| Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus | Q45734536 | ||
| An apparently new enterovirus isolated from patients with disease of the central nervous system | Q46144493 | ||
| The circulation of subgenogroups B5 and C5 of enterovirus 71 in Taiwan from 2006 to 2007. | Q46427197 | ||
| Cross-antigenicity among EV71 strains from different genogroups isolated in Yamagata, Japan, between 1990 and 2007. | Q46550828 | ||
| Acute encephalomyelitis during an outbreak of enterovirus type 71 infection in Taiwan: report of an autopsy case with pathologic, immunofluorescence, and molecular studies. | Q47809736 | ||
| Molecular characterization of enteroviruses detected in Gyeong-Ju and Po-Hang provinces of Korea in 2003. | Q48063933 | ||
| Evolutionary trajectory of the VP1 gene of human enterovirus 71 genogroup B and C viruses | Q48065338 | ||
| Asymptomatic circulation of HEV71 in Norway | Q48084750 | ||
| Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys | Q48142407 | ||
| Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema | Q48235723 | ||
| Complete sequence analyses of enterovirus 71 strains from fatal and non-fatal cases of the hand, foot and mouth disease outbreak in Singapore (2000). | Q48266466 | ||
| Cardiac troponin I: a reliable marker and early myocardial involvement with meningoencephalitis after fatal enterovirus-71 infection | Q48284752 | ||
| Fatal enterovirus 71 encephalomyelitis | Q48335107 | ||
| Neurogenic pulmonary oedema and enterovirus 71 encephalomyelitis | Q48359714 | ||
| Fulminant neurogenic pulmonary oedema with hand, foot, and mouth disease | Q48405572 | ||
| Comparison of heart failure in children with enterovirus 71 rhombencephalitis and cats with norepinephrine cardiotoxicity | Q48437203 | ||
| Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis | Q48464853 | ||
| Pathologic characterization of a murine model of human enterovirus 71 encephalomyelitis. | Q50647112 | ||
| High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture. | Q51143326 | ||
| Prevalence of enteroviruses in hot spring recreation areas of Taiwan. | Q54277070 | ||
| HLA-A33 is associated with susceptibility to enterovirus 71 infection. | Q54505115 | ||
| Molecular detection and prevalence of enterovirus within environmental water in Taiwan. | Q54550715 | ||
| Genetic diversity of enterovirus 71 associated with hand, foot and mouth disease epidemics in Japan from 1983 to 2003. | Q54590135 | ||
| Risk Factors of Enterovirus 71 Infection and Associated Hand, Foot, and Mouth Disease/Herpangina in Children During an Epidemic in Taiwan | Q56879053 | ||
| Altered cellular but not humoral reactions in children with complicated enterovirus 71 infections in Taiwan | Q56905319 | ||
| Evolution of EV71 genogroup in Taiwan from 1998 to 2005: An emerging of subgenogroup C4 of EV71 | Q56938651 | ||
| P433 | issue | 11 | |
| P921 | main subject | pathogenesis | Q372016 |
| epidemiology | Q133805 | ||
| virology | Q7215 | ||
| P304 | page(s) | 778-790 | |
| P577 | publication date | 2010-10-18 | |
| P1433 | published in | Lancet Infectious Diseases | Q15724248 |
| P1476 | title | Virology, epidemiology, pathogenesis, and control of enterovirus 71. | |
| P478 | volume | 10 |
| Q33819507 | "Eczema coxsackium" and unusual cutaneous findings in an enterovirus outbreak |
| Q40376000 | 2-Year Efficacy, Immunogenicity, and Safety of Vigoo Enterovirus 71 Vaccine in Healthy Chinese Children: A Randomized Open-Label Study |
| Q40041215 | 293tExosome-mediated miR-146a transfer suppresses type I interferon response and facilitates EV71 infection. |
| Q40760981 | 2C Proteins of Enteroviruses Suppress IKKβ Phosphorylation by Recruiting Protein Phosphatase 1 |
| Q35917729 | A Broadly Cross-protective Vaccine Presenting the Neighboring Epitopes within the VP1 GH Loop and VP2 EF Loop of Enterovirus 71. |
| Q56787248 | A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge |
| Q36210435 | A Molecular Approach Applied to Enteroviruses Surveillance in Northern Taiwan, 2008-2012. |
| Q92511079 | A Novel Murine Model Expressing a Chimeric mSCARB2/hSCARB2 Receptor Is Highly Susceptible to Oral Infection with Clinical Isolates of Enterovirus 71 |
| Q37252917 | A Single Mutation in the VP1 of Enterovirus 71 Is Responsible for Increased Virulence and Neurotropism in Adult Interferon-Deficient Mice |
| Q27679681 | A Strain-Specific Epitope of Enterovirus 71 Identified by Cryo-Electron Microscopy of the Complex with Fab from Neutralizing Antibody |
| Q58801223 | A VP1 mutation acquired during an enterovirus 71 disseminated infection confers heparan sulfate binding ability and modulates ex vivo tropism |
| Q38831138 | A bivalent virus-like particle based vaccine induces a balanced antibody response against both enterovirus 71 and norovirus in mice |
| Q42231743 | A booster dose of an inactivated enterovirus 71 vaccine in chinese young children: a randomized, double-blind, placebo-controlled clinical trial |
| Q27334321 | A clinically authentic mouse model of enterovirus 71 (EV-A71)-induced neurogenic pulmonary oedema |
| Q41511681 | A cluster of acute flaccid paralysis and cranial nerve dysfunction temporally associated with an outbreak of enterovirus D68 in children in Colorado, USA. |
| Q42222745 | A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses |
| Q43273718 | A comparative study of multiple clinical enterovirus 71 isolates and evaluation of cross protection of inactivated vaccine strain FY-23 K-B in vitro |
| Q39508462 | A generic assay for whole-genome amplification and deep sequencing of enterovirus A71. |
| Q39303241 | A laboratory evaluation of medicinal herbs used in china for the treatment of hand, foot, and mouth disease |
| Q40153226 | A neonatal gnotobiotic pig model of human enterovirus 71 infection and associated immune responses |
| Q40925262 | A new EV71 VP3 epitope in norovirus P particle vector displays neutralizing activity and protection in vivo in mice |
| Q37157440 | A new animal model containing human SCARB2 and lacking stat-1 is highly susceptible to EV71 |
| Q35826494 | A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection |
| Q40243159 | A novel combined vaccine based on monochimeric VLP co-displaying multiple conserved epitopes against enterovirus 71 and varicella-zoster virus |
| Q35796304 | A novel recombinant lineage's contribution to the outbreak of coxsackievirus A6-associated hand, foot and mouth disease in Shanghai, China, 2012-2013 |
| Q40704084 | A safe and sensitive enterovirus A71 infection model based on human SCARB2 knock-in mice |
| Q46825689 | A safety study of inactivated Enterovirus 71 vaccine |
| Q93161924 | A second open reading frame in human enterovirus determines viral replication in intestinal epithelial cells |
| Q34070570 | A single nucleotide in stem loop II of 5'-untranslated region contributes to virulence of enterovirus 71 in mice |
| Q42211021 | A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice |
| Q45354931 | A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge |
| Q55099892 | A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity. |
| Q38736590 | ARRDC4 regulates enterovirus 71-induced innate immune response by promoting K63 polyubiquitination of MDA5 through TRIM65. |
| Q33755064 | Activation of JNK1/2 and p38 MAPK signaling pathways promotes enterovirus 71 infection in immature dendritic cells |
| Q38601797 | Acute Flaccid Myelitis in German Children in 2016-the Return of Polio? |
| Q59357875 | Acute Flaccid Paralysis and Enteroviral Infections |
| Q30832727 | Acute encephalitis in children: Progress and priorities from an Australasian perspective |
| Q34635242 | Adaptation of enterovirus 71 to adult interferon deficient mice |
| Q64098466 | Advances in Antigenic Peptide-Based Vaccine and Neutralizing Antibodies against Viruses Causing Hand, Foot, and Mouth Disease |
| Q92848842 | Advances in Vaccines |
| Q36247990 | African Non-Human Primates Host Diverse Enteroviruses |
| Q36200131 | Age patterns and transmission characteristics of hand, foot and mouth disease in China |
| Q37381949 | Ambulatory Pediatric Surveillance of Hand, Foot and Mouth Disease as Signal of an Outbreak of Coxsackievirus A6 Infections, France, 2014-2015 |
| Q37243489 | Amphotericin B Inhibits Enterovirus 71 Replication by Impeding Viral Entry. |
| Q58795956 | Amplification and next generation sequencing of near full-length human enteroviruses for identification and characterisation from clinical samples |
| Q24297078 | An RNA virus hijacks an incognito function of a DNA repair enzyme |
| Q55652518 | An assessment of a pediatric early warning system score in severe hand-foot-and-mouth disease children: To detect clinical deterioration in hospitalized children. |
| Q35740892 | An enterovirus 71 strain causes skeletal muscle damage in infected mice |
| Q35621734 | An epidemic analysis of hand, foot, and mouth disease in Zunyi, China between 2012 and 2014 |
| Q92968336 | An inactivated enterovirus 71 vaccine is safe and immunogenic in healthy adults: A phase I, double blind, randomized, placebo-controlled, study of two dosages |
| Q33724967 | An inactivated hand-foot-and-mouth disease vaccine using the enterovirus 71 (C4a) strain isolated from a Korean patient induces a strong immunogenic response in mice. |
| Q89807228 | An infectious clone of enterovirus 71(EV71) that is capable of infecting neonatal immune competent mice without adaptive mutations |
| Q38405180 | Analysis of EV71 infection progression using triple-SILAC-based proteomics approach |
| Q57490132 | Analysis of an Imported Subgenotype C2 Strain of Human Enterovirus 71 in Beijing, China, 2015 |
| Q33806668 | Analysis of cross-reactive neutralizing antibodies in human HFMD serum with an EV71 pseudovirus-based assay |
| Q38833043 | Antibodies to P-selectin glycoprotein ligand-1 block dendritic cell-mediated enterovirus 71 transmission and prevent virus-induced cells death. |
| Q39255114 | Antigenic analysis of divergent genotypes human Enterovirus 71 viruses by a panel of neutralizing monoclonal antibodies: current genotyping of EV71 does not reflect their antigenicity. |
| Q66679210 | Antiviral Efficacy of Flavonoids against Enterovirus 71 Infection in Vitro and in Newborn Mice |
| Q42254382 | Antiviral activity of GuiQi polysaccharides against enterovirus 71 in vitro |
| Q37037951 | Antiviral activity of Lactobacillus reuteri Protectis against Coxsackievirus A and Enterovirus 71 infection in human skeletal muscle and colon cell lines |
| Q55112504 | Antiviral and Inflammatory Cellular Signaling Associated with Enterovirus 71 Infection. |
| Q39206081 | Antiviral effects of Phyllanthus urinaria containing corilagin against human enterovirus 71 and Coxsackievirus A16 in vitro |
| Q39282870 | Antiviral protection against enterovirus 71 mediated by autophagy induction following FLICE-inhibitory protein inactivation |
| Q35351497 | Apigenin inhibits enterovirus-71 infection by disrupting viral RNA association with trans-acting factors |
| Q92786658 | Assessing the efficacy and safety of magnesium sulfate for management of autonomic nervous system dysregulation in Vietnamese children with severe hand foot and mouth disease |
| Q40335707 | Association of Toll-like receptor 3 gene polymorphism with the severity of enterovirus 71 infection in Chinese children. |
| Q42265407 | Association of functional polymorphisms in the MxA gene with susceptibility to enterovirus 71 infection |
| Q33602804 | Attenuation of human enterovirus 71 high-replication-fidelity variants in AG129 mice |
| Q36767670 | Autoimmunity in picornavirus infections |
| Q38963513 | Basic reproduction number of coxsackievirus type A6 and A16 and enterovirus 71: estimates from outbreaks of hand, foot and mouth disease in Singapore, a tropical city-state |
| Q35156827 | Bayesian analysis for inference of an emerging epidemic: citrus canker in urban landscapes |
| Q40337068 | Biological characteristics of different epidemic enterovirus 71 strains and their pathogeneses in neonatal mice and rhesus monkeys |
| Q42277791 | Breastfeeding, previous Epstein-Barr virus infection, Enterovirus 71 infection, and rural residence are associated with the severity of hand, foot, and mouth disease |
| Q35689929 | Broad protection with an inactivated vaccine against primary-isolated lethal enterovirus 71 infection in newborn mice |
| Q56880960 | CNS Infections |
| Q54213252 | Caspase-3 Inhibition Attenuates the Cytopathic Effects of EV71 Infection. |
| Q37717052 | Cell and tissue tropism of enterovirus 71 and other enteroviruses infections |
| Q33602842 | Cell surface vimentin is an attachment receptor for enterovirus 71. |
| Q90071047 | Cellular Caspase-3 Contributes to EV-A71 2Apro-Mediated Down-Regulation of IFNAR1 at the Translation Level |
| Q92559736 | Cellular receptors for enterovirus A71 |
| Q34406820 | Challenges to licensure of enterovirus 71 vaccines |
| Q36099529 | Changes in enterovirus serotype constituent ratios altered the clinical features of infected children in Guangdong Province, China, from 2010 to 2013 |
| Q55709315 | Changes in the EV-A71 Genome through Recombination and Spontaneous Mutations: Impact on Virulence. |
| Q36965378 | Characterisation of enterovirus 71 replication kinetics in human colorectal cell line, HT29. |
| Q92612343 | Characteristics of enterovirus 71-induced cell death and genome scanning to identify viral genes involved in virus-induced cell apoptosis |
| Q57477507 | Characterization of Critical Functions of Long Non-Coding RNAs and mRNAs in Rhabdomyosarcoma Cells and Mouse Skeletal Muscle Infected by 71 Using RNA-Seq |
| Q28744474 | Characterization of an outbreak of hand, foot, and mouth disease in Nanchang, China in 2010 |
| Q28588052 | Characterization of enterovirus 71 infection and associated outbreak of Hand, Foot, and Mouth Disease in Shawo of China in 2012 |
| Q34221164 | Characterization of full-length enterovirus 71 strains from severe and mild disease patients in northeastern China |
| Q40113232 | Characterization of human enterovirus71 virus-like particles used for vaccine antigens. |
| Q38832137 | Characterizing Enterovirus 71 and Coxsackievirus A16 virus-like particles production in insect cells. |
| Q57042567 | Chinese guidelines for the diagnosis and treatment of hand, foot and mouth disease (2018 edition) |
| Q35010174 | Chlorogenic acid inhibits the replication and viability of enterovirus 71 in vitro |
| Q55361342 | Circulating Salivary miRNA hsa-miR-221 as Clinically Validated Diagnostic Marker for Hand, Foot, and Mouth Disease in Pediatric Patients. |
| Q34525982 | Circulation of Coxsackievirus A10 and A6 in hand-foot-mouth disease in China, 2009-2011. |
| Q92215747 | Circulation of non-polio enteroviruses in 24 EU and EEA countries between 2015 and 2017: a retrospective surveillance study |
| Q33634281 | Clinical and epidemiological characteristics of adult hand, foot, and mouth disease in northern Zhejiang, China, May 2008-November 2013. |
| Q50553653 | Clinical and virological features of enterovirus 71 infections in Denmark, 2005 to 2008. |
| Q64110466 | Clinical characteristics and managements of severe hand, foot and mouth disease caused by enterovirus A71 and coxsackievirus A16 in Shanghai, China |
| Q92142587 | Clinical characteristics of enterovirus A71 neurological disease during an outbreak in children in Colorado, USA, in 2018: an observational cohort study |
| Q36977606 | Clinical evaluation for batch consistency of an inactivated enterovirus 71 vaccine in a large-scale phase 3 clinical trial |
| Q91704057 | Co-circulation of coxsackieviruses A-6, A-10, and A-16 causes hand, foot, and mouth disease in Guangzhou city, China |
| Q41339219 | Combination of intratypic and intertypic recombinant events in EV71: a novel evidence for the "triple-recombinant" strains of genotype A viruses in Mainland China from 2008 to 2010. |
| Q34430681 | Comparative analysis of the immunogenicity and protective effects of inactivated EV71 vaccines in mice |
| Q38364080 | Comparative epidemiology and virology of fatal and nonfatal cases of hand, foot and mouth disease in mainland China from 2008 to 2014. |
| Q34469442 | Comparing molecular methods for early detection and serotyping of enteroviruses in throat swabs of pediatric patients |
| Q39150656 | Comparison analysis of microRNAs in response to EV71 and CA16 infection in human bronchial epithelial cells by high-throughput sequencing to reveal differential infective mechanisms |
| Q40216283 | Complete Genome Sequence of an Enterovirus 71 Strain Isolated from the Cerebrospinal Fluid of a Child with Severe Hand-Foot-and-Mouth Disease in Yunnan, China, 2013. |
| Q60044716 | Complete genome analysis demonstrates multiple introductions of enterovirus 71 and coxsackievirus A16 recombinant strains into Thailand during the past decade |
| Q40611177 | Complete genome sequence analysis of enterovirus 71 isolated from children with hand, foot, and mouth disease in Thailand, 2012-2014. |
| Q37025363 | Complete genome sequence of a human enterovirus 71 strain isolated in brunei in 2006 |
| Q41271235 | Complete genome sequence of a new recombinant echovirus 25 strain isolated from a neonatal patient with hand, foot, and mouth disease complicated by encephalitis in Beijing, China |
| Q33701681 | Concentration and purification of enterovirus 71 using a weak anion-exchange monolithic column |
| Q27677562 | Conformational Plasticity of the 2A Proteinase from Enterovirus 71 |
| Q26828723 | Considerations for developing an immunization strategy with enterovirus 71 vaccine |
| Q36298942 | Continuous veno-venous hemofiltration for treatment of enterovirus 71-induced fulminant cardiopulmonary failure: a case report |
| Q37064293 | Cooperative effect of the VP1 amino acids 98E, 145A and 169F in the productive infection of mouse cell lines by enterovirus 71 (BS strain). |
| Q41493595 | Correlation of an interleukin-4 gene polymorphism with susceptibility to severe enterovirus 71 infection in Chinese children |
| Q40047717 | Cost-effectiveness of a national enterovirus 71 vaccination program in China |
| Q89965191 | Coxsackievirus A6 Induces Necroptosis for Viral Production |
| Q39007590 | Coxsackievirus A6 and enterovirus 71 causing hand, foot and mouth disease in Cuba, 2011-2013. |
| Q38538070 | Coxsackievirus A6: a new emerging pathogen causing hand, foot and mouth disease outbreaks worldwide |
| Q34302525 | Coxsackievirus B4 myocarditis and meningoencephalitis in newborn twins |
| Q34607995 | Cross-reactive neutralizing antibody responses to enterovirus 71 infections in young children: implications for vaccine development |
| Q33887710 | Cryo-electron microscopy study of insect cell-expressed enterovirus 71 and coxsackievirus a16 virus-like particles provides a structural basis for vaccine development |
| Q47574078 | Crystal structure of the coxsackievirus A16 RNA-dependent RNA polymerase elongation complex reveals novel features in motif A dynamics |
| Q27303732 | Cyclical Patterns of Hand, Foot and Mouth Disease Caused by Enterovirus A71 in Malaysia |
| Q34177586 | Delivery of human EV71 receptors by adeno-associated virus increases EV71 infection-induced local inflammation in adult mice. |
| Q36019166 | Detecting spatial-temporal cluster of hand foot and mouth disease in Beijing, China, 2009-2014 |
| Q34760345 | Detection of hand, foot and mouth disease in the yucatan peninsula of Mexico |
| Q40889243 | Determinants of EV71 immunogenicity and protection against lethal challenge in a mouse model |
| Q33964363 | Development and evaluation of reverse transcription-loop-mediated isothermal amplification assay for rapid detection of enterovirus 71 |
| Q39239508 | Development of a Coxsackievirus A16 neutralization assay based on pseudoviruses for measurement of neutralizing antibody titer in human serum |
| Q36200660 | Development of a fluorescence resonance energy transfer-based intracellular assay to identify novel enterovirus 71 antivirals |
| Q49343123 | Development of a high-growth enterovirus 71 vaccine candidate inducing cross-reactive neutralizing antibody responses. |
| Q38195326 | Development of enterovirus 71 vaccines: from the lab bench to Phase III clinical trials |
| Q44580335 | Diagnosis of hand, foot, and mouth disease caused by EV71 and other enteroviruses by a one-step, single tube, duplex RT-PCR. |
| Q33713090 | Different microRNA profiles reveal the diverse outcomes induced by EV71 and CA16 infection in human umbilical vein endothelial cells using high-throughput sequencing |
| Q35967663 | Differential Regulation of TLR Signaling on the Induction of Antiviral Interferons in Human Intestinal Epithelial Cells Infected with Enterovirus 71 |
| Q38885207 | Differential expression of miRNAs in enterovirus 71-infected cells |
| Q36507273 | Direct Identification of Enteroviruses in Cerebrospinal Fluid of Patients with Suspected Meningitis by Nested PCR Amplification. |
| Q55403148 | Discovery of Enterovirus A71-like nonstructural genomes in recent circulating viruses of the Enterovirus A species. |
| Q36256473 | Disease burden of enterovirus 71 in rural central China: A community-based survey |
| Q33958090 | Display of VP1 on the surface of baculovirus and its immunogenicity against heterologous human enterovirus 71 strains in mice |
| Q84446181 | Display of enterovirus 71 VP1 on baculovirus as a type II transmembrane protein elicits protective B and T cell responses in immunized mice |
| Q38391011 | Distribution of EV71 receptors SCARB2 and PSGL-1 in human tissues |
| Q41656493 | Distribution of enterovirus 71 RNA in inflammatory cells infiltrating different tissues in fatal cases of hand, foot, and mouth disease |
| Q39296711 | Dominant CD4-dependent RNA-dependent RNA polymerase-specific T-cell responses in children acutely infected with human enterovirus 71 and healthy adult controls |
| Q33653696 | Dynamic Interaction of Enterovirus 71 and Dendritic Cells in Infected Neonatal Rhesus Macaques |
| Q93196204 | EV71 3C protease induces apoptosis by cleavage of hnRNP A1 to promote apaf-1 translation |
| Q51873171 | EV71 vaccine: protection from a previously neglected disease. |
| Q41583962 | EV71 vaccines: a first step towards multivalent hand, foot and mouth disease vaccines |
| Q36496385 | EV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challenge |
| Q37289553 | EV71-infected CD14(+) cells modulate the immune activity of T lymphocytes in rhesus monkeys |
| Q42201175 | Early dexamethasone treatment exacerbates enterovirus 71 infection in mice |
| Q92300827 | Economic Burden Attributed to Children Presenting to Hospitals With Hand, Foot, and Mouth Disease in Vietnam |
| Q41995642 | Economic costs and health-related quality of life for hand, foot and mouth disease (HFMD) patients in China |
| Q28606867 | Efficacy of a Trivalent Hand, Foot, and Mouth Disease Vaccine against Enterovirus 71 and Coxsackieviruses A16 and A6 in Mice |
| Q34347924 | Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial |
| Q64123371 | Efficient expression of enterovirus 71 based on virus-like particles vaccine |
| Q36774145 | Elevated expression of circulating miR876-5p is a specific response to severe EV71 infections |
| Q44663288 | Elevation of human leukocyte antigen-G expression is associated with the severe encephalitis associated with neurogenic pulmonary edema caused by Enterovirus 71. |
| Q33729001 | Elucidating the host-pathogen interaction between human colorectal cells and invading Enterovirus 71 using transcriptomics profiling |
| Q93165194 | Emerging Role for Acyl-CoA Binding Domain Containing 3 at Membrane Contact Sites During Viral Infection |
| Q92320626 | Endophilin-A2-mediated endocytic pathway is critical for enterovirus 71 entry into caco-2 cells |
| Q47127923 | Enhanced human enterovirus 71 infection by endocytosis inhibitors reveals multiple entry pathways by enterovirus causing hand-foot-and-mouth diseases |
| Q57049727 | Enhanced neutralizing antibody response induced by inactivated enterovirus 71 in cynomolgus monkeys |
| Q37347350 | Enterovirus 71 2B Induces Cell Apoptosis by Directly Inducing the Conformational Activation of the Proapoptotic Protein Bax |
| Q37560750 | Enterovirus 71 3C Promotes Apoptosis through Cleavage of PinX1, a Telomere Binding Protein |
| Q89782338 | Enterovirus 71 Infection Shapes Host T Cell Receptor Repertoire and Presumably Expands VP1-Specific TCRβ CDR3 Cluster |
| Q38698005 | Enterovirus 71 Inhibits Pyroptosis through Cleavage of Gasdermin D. |
| Q92257825 | Enterovirus 71 Represses Interleukin Enhancer-Binding Factor 2 Production and Nucleus Translocation to Antagonize ILF2 Antiviral Effects |
| Q64106884 | Enterovirus 71 Suppresses miR-17-92 Cluster Through Up-Regulating Methylation of the miRNA Promoter |
| Q34916727 | Enterovirus 71 binding to PSGL-1 on leukocytes: VP1-145 acts as a molecular switch to control receptor interaction |
| Q51874762 | Enterovirus 71 encephalitis: a new vaccine on the horizon? |
| Q34623650 | Enterovirus 71 induces degradation of TRIM38, a potential E3 ubiquitin ligase |
| Q39864398 | Enterovirus 71 induces dsRNA/PKR-dependent cytoplasmic redistribution of GRP78/BiP to promote viral replication |
| Q30238518 | Enterovirus 71 infection and vaccines |
| Q35727396 | Enterovirus 71 infection in children with hand, foot, and mouth disease in Shanghai, China: epidemiology, clinical feature and diagnosis |
| Q54216673 | Enterovirus 71 infection of human airway organoids reveals VP1-145 as a viral infectivity determinant. |
| Q35158059 | Enterovirus 71 mediates cell cycle arrest in S phase through non-structural protein 3D. |
| Q42205122 | Enterovirus 71 outbreak in Northern Sydney, 2013: case series and initial response |
| Q42243025 | Enterovirus 71 pathogenicity in monkeys and cotton rats |
| Q41922848 | Enterovirus 71 protease 2Apro and 3Cpro differentially inhibit the cellular endoplasmic reticulum-associated degradation (ERAD) pathway via distinct mechanisms, and enterovirus 71 hijacks ERAD component p97 to promote its replication. |
| Q42588563 | Enterovirus 71 related severe hand, foot and mouth disease outbreaks in South-East Asia: current situation and ongoing challenges |
| Q40222242 | Enterovirus 71 suppresses interferon responses by blocking Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling through inducing karyopherin-α1 degradation |
| Q39253638 | Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor. |
| Q44783439 | Enterovirus 71 vaccine: when will it be available? |
| Q38840182 | Enterovirus 71: a whole virion inactivated enterovirus 71 vaccine |
| Q27468727 | Enterovirus A71 DNA-Launched Infectious Clone as a Robust Reverse Genetic Tool |
| Q42935758 | Enterovirus A71 Genogroups C and E in Children with Acute Flaccid Paralysis, West Africa |
| Q93079877 | Enterovirus A71 Infection Activates Human Immune Responses and Induces Pathological Changes in Humanized Mice |
| Q57092532 | Enterovirus A71 Infection, Thailand, 2017 |
| Q92032316 | Enterovirus A71 Oncolysis of Malignant Gliomas |
| Q64091551 | Enterovirus A71 Phenotypes Causing Hand, Foot and Mouth Disease, Vietnam |
| Q54260296 | Enterovirus A71 Proteins: Structure and Function. |
| Q92504655 | Enterovirus A71 neurologic complications and long-term sequelae |
| Q42673338 | Enterovirus A71 subgenotype B5, France, 2013 |
| Q50925408 | Enterovirus Contamination in Pediatric Hospitals: A Neglected Part of the Hand-Foot-Mouth Disease Transmission Chain in China? |
| Q36563471 | Enterovirus D68 receptor requirements unveiled by haploid genetics. |
| Q34697319 | Enterovirus infections of the central nervous system |
| Q55303952 | Enterovirus serotypes in patients with central nervous system and respiratory infections in Viet Nam 1997-2010. |
| Q44079611 | Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles. |
| Q64990179 | Enterovirus type 71-immunized chicken egg yolk immunoglobulin has cross antiviral activity against coxsackievirus A16 in vitro. |
| Q33927772 | Enterovirus71 (EV71) utilise host microRNAs to mediate host immune system enhancing survival during infection |
| Q38845816 | Enterovirus71 virus-like particles produced from insect cells and purified by multistep chromatography elicit strong humoral immune responses in mice |
| Q36571245 | Enteroviruses in the early 21st century: new manifestations and challenges |
| Q58125726 | Environmental Surveillance Reveals Complex Enterovirus Circulation Patterns in Human Populations |
| Q57096427 | Epidemic characteristics of hand, foot, and mouth disease in Shanghai from 2009 to 2010: Enterovirus 71 subgenotype C4 as the primary causative agent and a high incidence of mixed infections with coxsackievirus A16 |
| Q58744923 | Epidemic dynamics, interactions and predictability of enteroviruses associated with hand, foot and mouth disease in Japan |
| Q35793525 | Epidemiological Characteristics and Spatial-Temporal Clusters of Hand, Foot, and Mouth Disease in Zhejiang Province, China, 2008-2012 |
| Q33653024 | Epidemiological and aetiological characteristics of hand, foot, and mouth disease in Shijiazhuang City, Hebei province, China, 2009-2012. |
| Q33797507 | Epidemiological and clinical characteristics of children who died from hand, foot and mouth disease in Vietnam, 2011. |
| Q35160633 | Epidemiological and etiological characteristics of hand, foot, and mouth disease in Henan, China, 2008-2013 |
| Q40083958 | Epidemiological and etiological characteristics of herpangina and hand foot mouth diseases in Jiangsu, China, 2013-2014. |
| Q40211229 | Epidemiological and genetic analysis concerning the non-enterovirus 71 and non-coxsackievirus A16 causative agents related to hand, foot and mouth disease in Anyang city, Henan Province, China, from 2011 to 2015. |
| Q47118265 | Epidemiological and genetic characteristics of EV71 in hand, foot, and mouth disease in Guangxi, southern China, from 2010 to 2015. |
| Q58719025 | Epidemiological characteristics and influential factors of hand, foot, and mouth disease reinfection in Wuxi, China, 2008-2016 |
| Q59791661 | Epidemiological features and spatial clusters of hand, foot, and mouth disease in Qinghai Province, China, 2009-2015 |
| Q38835845 | Epidemiological features and spatio-temporal clusters of hand-foot-mouth disease at town level in Fuyang, Anhui Province, China (2008-2013). |
| Q37607514 | Epidemiology and seroepidemiology of human enterovirus 71 among Thai populations |
| Q36107261 | Epidemiology and virologic investigation of human enterovirus 71 infection in the Republic of Korea from 2007 to 2012: a nationwide cross-sectional study |
| Q47441876 | Epidemiology of hand, foot and mouth disease in China, 2008 to 2015 prior to the introduction of EV-A71 vaccine |
| Q59356338 | Establishment and characterization of an oral gerbil model for a non-mouse-adapted enterovirus 71 strain |
| Q91077168 | Establishment of Asia-Pacific Network for Enterovirus Surveillance |
| Q55967992 | Etiology, pathogenesis, antivirals and vaccines of hand, foot, and mouth disease |
| Q46025240 | Evidences for intertypic and intratypic recombinant events in EV71 of hand, foot and mouth disease during an epidemic in Hubei Province, China, 2011. |
| Q47613756 | Evolution and Spatiotemporal Dynamics of Enterovirus A71 Subgenogroups in Vietnam. |
| Q41673206 | Exploration of the anti-enterovirus activity of a series of pleconaril/pirodavir-like compounds |
| Q37644206 | Expression of enterovirus 71 capsid protein VP1 in Escherichia coli and its clinical application |
| Q35625893 | Expression of enterovirus 71 virus-like particles in transgenic enoki (Flammulina velutipes). |
| Q42548719 | Fatal case of enterovirus 71 infection and rituximab therapy, france, 2012. |
| Q51785150 | Fibronectin facilitates EV71 infection by mediating its entry. |
| Q42236991 | Fifteen years of acute flaccid paralysis surveillance in Hong Kong: findings from 1997 to 2011. |
| Q40963784 | First fatal case of CNS infection caused by Enterovirus A in Brazil. |
| Q39302654 | First isolation and genomic characterization of enterovirus A71 and coxsackievirus A16 from hand foot and mouth disease patients in the Lao PDR. |
| Q89633869 | Flavonoids as Antiviral Agents for Enterovirus A71 (EV-A71) |
| Q38715188 | Flos Farfarae Inhibits Enterovirus 71-Induced Cell Injury by Preventing Viral Replication and Structural Protein Expression |
| Q58778314 | Flt3 ligand treatment reduces enterovirus A71 lethality in mice with enhanced B cell responses |
| Q40115312 | Fluorination of Naturally Occurring N⁶-Benzyladenosine Remarkably Increased Its Antiviral Activity and Selectivity. |
| Q35053266 | Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers |
| Q35153758 | Formononetin inhibits enterovirus 71 replication by regulating COX- 2/PGE₂ expression |
| Q49428880 | Full-Genome Sequence of an Enterovirus 71 Strain Isolated from a Throat Swab from a Child with Severe Hand-Foot-and-Mouth Disease in Changzhou, China, in 2017. |
| Q36851382 | Full-Genome Sequences of Seven Fatal Enterovirus 71 Strains Isolated in Shenzhen, China, in 2014. |
| Q42154884 | GITRL as a genetic adjuvant enhances enterovirus 71 VP1 DNA vaccine immunogenicity. |
| Q41236688 | Generation and characterization of a protective mouse monoclonal antibody against human enterovirus 71. |
| Q52649128 | Genetic Characterization of Enterovirus A71 Circulating in Africa. |
| Q38975812 | Genetic characterization of Enterovirus 71 strains circulating in Vietnam in 2012. |
| Q36750494 | Genetic characterization of a Coxsackie A9 virus associated with aseptic meningitis in Alberta, Canada in 2010. |
| Q41525585 | Genetic characterization of human coxsackievirus A6 variants associated with atypical hand, foot and mouth disease: a potential role of recombination in emergence and pathogenicity. |
| Q36252818 | Genetic diversity and molecular characterization of enteroviruses from sewage-polluted urban and rural rivers in the Philippines |
| Q33940086 | Genetic diversity of human enterovirus 68 strains isolated in Kenya using the hypervariable 3'-end of VP1 gene |
| Q35785327 | Genotypes of the Enterovirus Causing Hand Foot and Mouth Disease in Shanghai, China, 2012-2013. |
| Q36614813 | Genotyping of enteroviruses isolated in Kenya from pediatric patients using partial VP1 region |
| Q38756005 | Global emergence of enterovirus D68: a systematic review |
| Q38452318 | Global gene expression analysis of peripheral blood mononuclear cells in rhesus monkey infants with CA16 infection-induced HFMD. |
| Q98232921 | Global profiling of the alternative splicing landscape reveals transcriptomic diversity during the early phase of enterovirus 71 infection |
| Q38404281 | Global quantitative proteomic analysis of human glioma cells profiled host protein expression in response to enterovirus type 71 infection |
| Q42272784 | Glycyrrhizic acid as the antiviral component of Glycyrrhiza uralensis Fisch. against coxsackievirus A16 and enterovirus 71 of hand foot and mouth disease |
| Q30249022 | Hand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy. |
| Q59139034 | Hand, foot and mouth disease and herpangina caused by enterovirus A71 infections: a review of enterovirus A71 molecular epidemiology, pathogenesis, and current vaccine development |
| Q48092976 | Hand, foot and mouth disease: current knowledge on clinical manifestations, epidemiology, aetiology and prevention |
| Q35634754 | Hand, foot, and mouth disease in China: patterns of spread and transmissibility |
| Q41994144 | Hand, foot, and mouth disease in mainland China before it was listed as category C disease in May, 2008. |
| Q37044874 | Hand-Washing: The Main Strategy for Avoiding Hand, Foot and Mouth Disease |
| Q33460080 | Hand-foot-and-mouth disease and weather factors in Guangzhou, southern China |
| Q33463240 | Hand-foot-and-mouth disease epidemiological status and relationship with meteorological variables in Guangzhou, southern China, 2008-2012. |
| Q45324939 | Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice |
| Q62487903 | High Permissiveness for Genetic Exchanges between Enteroviruses of Species A, including Enterovirus 71, Favors Evolution through Intertypic Recombination in Madagascar |
| Q40217883 | High prevalence of coxsackievirus A2 in children with herpangina in Thailand in 2015. |
| Q37360738 | High-affinity interaction of hnRNP A1 with conserved RNA structural elements is required for translation and replication of enterovirus 71. |
| Q41373115 | High-yield production of recombinant virus-like particles of enterovirus 71 in Pichia pastoris and their protective efficacy against oral viral challenge in mice |
| Q42214658 | Histopathological features and distribution of EV71 antigens and SCARB2 in human fatal cases and a mouse model of enterovirus 71 infection |
| Q92238908 | Host Genetics, Innate Immune Responses, and Cellular Death Pathways in Poliomyelitis Patients |
| Q35383186 | Host factors in enterovirus 71 replication |
| Q34033907 | How to understand the efficacy measurements for enterovirus type 71 vaccine? |
| Q64105876 | Hsp27 Responds to and Facilitates Enterovirus A71 Replication by Enhancing Viral Internal Ribosome Entry Site-Mediated Translation |
| Q36947214 | Human IgG Fc promotes expression, secretion and immunogenicity of enterovirus 71 VP1 protein |
| Q36859366 | Human IgG subclasses against enterovirus Type 71: neutralization versus antibody dependent enhancement of infection |
| Q37654728 | Human enterovirus 71 protein interaction network prompts antiviral drug repositioning |
| Q40105691 | Human enteroviruses associated with and without diarrhea in Thailand between 2010 and 2016. |
| Q34321393 | Human rhinoviruses |
| Q99608333 | IRES-targeting small molecule inhibits enterovirus 71 replication via allosteric stabilization of a ternary complex |
| Q92130998 | Identification and molecular characterization of the first complete genome sequence of Human Parechovirus type 15 |
| Q35544351 | Identification of a common epitope between enterovirus 71 and human MED25 proteins which may explain virus-associated neurological disease |
| Q92240914 | Identification of immune and metabolic predictors of severe hand-foot-mouth disease |
| Q33963444 | Identification of luteolin as enterovirus 71 and coxsackievirus A16 inhibitors through reporter viruses and cell viability-based screening |
| Q34387141 | Identification of site-specific adaptations conferring increased neural cell tropism during human enterovirus 71 infection |
| Q56395701 | Immune Evasion of Enteroviruses Under Innate Immune Monitoring |
| Q43434704 | Immune responses to baculovirus-displayed enterovirus 71 VP1 antigen |
| Q35779269 | Immunity and clinical efficacy of an inactivated enterovirus 71 vaccine in healthy Chinese children: a report of further observations |
| Q33643774 | Immunization of N terminus of enterovirus 71 VP4 elicits cross-protective antibody responses. |
| Q36256455 | Immunogenicity and protective efficacy of an EV71 virus-like particle vaccine against lethal challenge in newborn mice |
| Q34324574 | Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial |
| Q92532366 | Immunogenicity and safety of an inactivated enterovirus A71 vaccine in children 3-6 years and 2-35 months of age- an open-label, randomized phase IIb clinical trial |
| Q33809953 | Immunogenicity studies of bivalent inactivated virions of EV71/CVA16 formulated with submicron emulsion systems. |
| Q91901438 | Immunogenicity, safety, cross-reaction, and immune persistence of an inactivated enterovirus A71 vaccine in children aged from two months to 11 years in Taiwan |
| Q35858037 | Immunologic Characterization of Cytokine Responses to Enterovirus 71 and Coxsackievirus A16 Infection in Children |
| Q36248450 | Immunological evaluation and comparison of different EV71 vaccine candidates |
| Q47145137 | Immunopathogenesis and Virus-Host Interactions of Enterovirus 71 in Patients with Hand, Foot and Mouth Disease |
| Q40044792 | Impact of Coxsackievirus A6 emergence on hand, foot, and mouth disease epidemic in Osaka City, Japan |
| Q36553419 | Impact of Human Enterovirus 71 Genotypes in Meningoencephalitis in Iran |
| Q48378763 | Impact of IL-10-1082A/G gene polymorphism on the severity of EV71 infection in Chinese children. |
| Q90227175 | Impact of RNA Virus Evolution on Quasispecies Formation and Virulence |
| Q40324476 | Impact of temperature variation between adjacent days on childhood hand, foot and mouth disease during April and July in urban and rural Hefei, China |
| Q30382068 | Implications of Age-Dependent Immune Responses to Enterovirus 71 Infection for Disease Pathogenesis and Vaccine Design. |
| Q92547222 | In Vitro and In Vivo Inhibition of the Infectivity of Human Enterovirus 71 by a Sulfonated Food Azo Dye, Brilliant Black BN |
| Q38726193 | In Vivo Imaging with Bioluminescent Enterovirus 71 Allows for Real-Time Visualization of Tissue Tropism and Viral Spread |
| Q48429651 | In enterovirus 71 encephalitis with cardio-respiratory compromise, elevated interleukin 1β, interleukin 1 receptor antagonist, and granulocyte colony-stimulating factor levels are markers of poor prognosis |
| Q39412134 | In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection |
| Q38977640 | In vitro inhibition of enterovirus 71 infection with a nickel ion/chitosan microcomposite |
| Q34287387 | In vivo time-related evaluation of a therapeutic neutralization monoclonal antibody against lethal enterovirus 71 infection in a mouse model |
| Q27321616 | Inactivated Enterovirus 71 Vaccine Produced by 200-L Scale Serum-Free Microcarrier Bioreactor System Provides Cross-Protective Efficacy in Human SCARB2 Transgenic Mouse |
| Q40605783 | Increased seroprevalence of Enterovirus 71 IgE antibodies in asthmatic compared with non-asthmatic children |
| Q41919543 | Independent evolution of tetraloop in enterovirus oriL replicative element and its putative binding partners in virus protein 3C. |
| Q58202560 | Inflammasomes in the gastrointestinal tract: infection, cancer and gut microbiota homeostasis |
| Q28541413 | Inhibition of Enterovirus 71 replication by 7-hydroxyflavone and diisopropyl-flavon7-yl Phosphate |
| Q39001023 | Inhibition of enterovirus 71 infection by antisense octaguanidinium dendrimer-conjugated morpholino oligomers |
| Q39021610 | Inhibition of miR-146a prevents enterovirus-induced death by restoring the production of type I interferon. |
| Q57817503 | Innate Immunity Evasion by Enteroviruses Linked to Epidemic Hand-Foot-Mouth Disease |
| Q26773329 | Innate Immunity and Immune Evasion by Enterovirus 71 |
| Q89752168 | Interchangeability of two Enterovirus 71 inactivated vaccines in Chinese children: A phase IV, open-label, and randomized controlled trial |
| Q91578240 | Interplays between Enterovirus A71 and the innate immune system |
| Q92144885 | Intra-host emergence of an enterovirus A71 variant with enhanced PSGL1 usage and neurovirulence |
| Q28604050 | Intravenous magnesium sulfate for the management of severe hand, foot, and mouth disease with autonomic nervous system dysregulation in Vietnamese children: study protocol for a randomized controlled trial |
| Q27010349 | Is a multivalent hand, foot, and mouth disease vaccine feasible? |
| Q40401421 | Laboratory Surveillance of Polio and Other Enteroviruses in High-Risk Populations and Environmental Samples |
| Q41921337 | Long non-coding RNA expression profiles in different severity EV71-infected hand foot and mouth disease patients. |
| Q34708584 | MDA5 plays a crucial role in enterovirus 71 RNA-mediated IRF3 activation |
| Q35005059 | MEK/ERK signaling pathway is required for enterovirus 71 replication in immature dendritic cells |
| Q33906139 | Machine Learning Algorithms for Risk Prediction of Severe Hand-Foot-Mouth Disease in Children |
| Q37114506 | Macrocyclic inhibitors of 3C and 3C-like proteases of picornavirus, norovirus, and coronavirus. |
| Q38082160 | Manifestations of HIV infection in the peripheral nervous system |
| Q88684253 | Mast cells contribute to Enterovirus 71 infection-induced pulmonary edema in neonatal mice |
| Q89835315 | Metabolic Reprogramming of Host Cells in Response to Enteroviral Infection |
| Q27468752 | Metagenomics Study of Viral Pathogens in Undiagnosed Respiratory Specimens and Identification of Human Enteroviruses at a Thailand Hospital |
| Q45324183 | MiR-16-5p mediates a positive feedback loop in EV71-induced apoptosis and suppresses virus replication |
| Q89554259 | MicroRNA 876-5p modulates EV-A71 replication through downregulation of host antiviral factors |
| Q26769980 | MicroRNA and Pathogenesis of Enterovirus Infection |
| Q35624818 | Microchip capillary electrophoresis with laser-induced fluorescence combined with one-step duplex reverse-transcription polymerase chain reaction for the rapid detection of Enterovirus 71 and Coxsackievirus A16 in throat swab specimens |
| Q38252747 | Mimics and chameleons in Guillain-Barré and Miller Fisher syndromes |
| Q40126540 | Modelling person-to-person transmission in an Enterovirus A71 orally infected hamster model of hand-foot-and-mouth disease and encephalomyelitis |
| Q92953658 | Modifications in the branched arms of a class of dual inhibitors of HIV and EV71 replication expand their antiviral spectrum |
| Q89804878 | Molecular Characterization and Clinical Description of Non-Polio Enteroviruses Detected in Stool Samples from HIV-Positive and HIV-Negative Adults in Ghana |
| Q36403436 | Molecular Epidemiology of Human Rhinoviruses and Enteroviruses Highlights Their Diversity in Sub-Saharan Africa |
| Q98577793 | Molecular characteristics of the VP1 region of enterovirus 71 strains in China |
| Q64069997 | Molecular characterization of enterovirus-A71 in children with acute flaccid paralysis in the Philippines |
| Q35942915 | Molecular characterization of human enteroviruses in the Central African Republic: uncovering wide diversity and identification of a new human enterovirus A71 genogroup |
| Q21132297 | Molecular comparison and evolutionary analyses of VP1 nucleotide sequences of new African human enterovirus 71 isolates reveal a wide genetic diversity |
| Q41172813 | Molecular epidemiology of an outbreak of hand, foot, and mouth disease associated with subgenotype C4a of enterovirus A71 in Nanchang, China in 2014. |
| Q35067894 | Molecular epidemiology of coxsackievirus A16: intratype and prevalent intertype recombination identified |
| Q35082588 | Molecular epidemiology of enterovirus 71 infection in the central region of Taiwan from 2002 to 2012. |
| Q37419883 | Molecular epidemiology of human enterovirus 71 at the origin of an epidemic of fatal hand, foot and mouth disease cases in Cambodia |
| Q33945658 | Monitoring antigenic variations of enterovirus 71: implications for virus surveillance and vaccine development |
| Q42247279 | Monitoring of seasonality of norovirus and other enteric viruses in Cameroon by real-time PCR: an exploratory study |
| Q58547577 | N6-methyladenosine modification and METTL3 modulate enterovirus 71 replication |
| Q41850827 | Natural occurrence and characterization of two internal ribosome entry site elements in a novel virus, canine picodicistrovirus, in the picornavirus-like superfamily. |
| Q98188945 | Neonatal hand, foot, and mouth disease due to coxsackievirus A6 in Shanghai |
| Q36518544 | Neuroepidemiology and the epidemiology of viral infections of the nervous system |
| Q24701724 | Neurotropic virus infections as the cause of immediate and delayed neuropathology |
| Q47383629 | Neurotropism In Vitro and Mouse Models of Severe and Mild Infection with Clinical Strains of Enterovirus 71. |
| Q92798042 | Neutralizing Antibodies against Enteroviruses in Patients with Hand, Foot and Mouth Disease |
| Q100692586 | Neutralizing antibody against Enterovirus-A71 in Thai children: A longitudinal study from birth to age 4 years |
| Q33951132 | New introductions of enterovirus 71 subgenogroup C4 strains, France, 2012 |
| Q92609814 | Newly emerged enterovirus-A71 C4 sublineage may be more virulent than B5 in the 2015-2016 hand-foot-and-mouth disease outbreak in northern Vietnam |
| Q35739874 | Norepinephrine and Epinephrine Enhanced the Infectivity of Enterovirus 71. |
| Q58740121 | Notes from the Field: Enterovirus A71 Neurologic Disease in Children - Colorado, 2018 |
| Q35831592 | Outbreak of febrile illness caused by coxsackievirus A4 in a nursery school in Beijing, China |
| Q54205680 | Outcomes following severe hand foot and mouth disease: A systematic review and meta-analysis. |
| Q36381397 | PD169316, a specific p38 inhibitor, shows antiviral activity against Enterovirus71. |
| Q61796005 | PLCβ2 negatively regulates the inflammatory response to virus infection by inhibiting phosphoinositide-mediated activation of TAK1 |
| Q37697706 | Paediatric Virology: A rapidly increasing educational challenge. |
| Q36501728 | Pancreatitis in hand-foot-and-mouth disease caused by enterovirus 71 |
| Q92860514 | Pathogenic characteristics of hand, foot and mouth disease in Shaanxi Province, China, 2010-2016 |
| Q40631491 | Pathologic Studies of Fatal Encephalomyelitis in Children Caused by Enterovirus 71. |
| Q60310065 | Pathologic and molecular studies of enterovirus 71 infection in a fatal case from a recent epidemic in China: A case report |
| Q35132329 | Phenotypic and genotypic characteristics of novel mouse cell line (NIH/3T3)-adapted human enterovirus 71 strains (EV71:TLLm and EV71:TLLmv). |
| Q35913916 | Phylodynamics of Enterovirus A71-Associated Hand, Foot, and Mouth Disease in Viet Nam. |
| Q34589966 | Phylogenetic analysis of Enterovirus 71 circulating in Beijing, China from 2007 to 2009 |
| Q30375266 | Phylogenetic analysis of the major causative agents of hand, foot and mouth disease in Suzhou City, Jiangsu province, China, in 2012-2013. |
| Q38703853 | Phylogeography of Coxsackievirus A16 Reveals Global Transmission Pathways and Recent Emergence and Spread of a Recombinant Genogroup |
| Q31056961 | Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates |
| Q39967464 | Pilot surveillance for childhood encephalitis in Australia using the Paediatric Active Enhanced Disease Surveillance (PAEDS) network |
| Q47553138 | Poorly neutralizing polyclonal antibody in vitro against coxsackievirus A16 circulating strains can prevent a lethal challenge in vivo. |
| Q60302591 | Population based hospitalization burden of laboratory-confirmed hand, foot and mouth disease caused by multiple enterovirus serotypes in Southern China |
| Q42254889 | Preclinical evaluation of the immunogenicity and safety of an inactivated enterovirus 71 candidate vaccine |
| Q37196295 | Prediction of Protection against Asian Enterovirus 71 Outbreak Strains by Cross-neutralizing Capacity of Serum from Dutch Donors, The Netherlands |
| Q38950180 | Prediction of signaling pathways involved in enterovirus 71 infection by algorithm analysis based on miRNA profiles and their target genes |
| Q33700137 | Prevalence and characterization of enterovirus infections among pediatric patients with hand foot mouth disease, herpangina and influenza like illness in Thailand, 2012. |
| Q35076317 | Prevalence of enteroviruses in children with and without hand, foot, and mouth disease in China |
| Q40124121 | Prevalence of enteroviruses in healthy populations and excretion of pathogens in patients with hand, foot, and mouth disease in a highly endemic area of southwest China |
| Q36321580 | Prevalence, type and concentration of human enterovirus and parechovirus in cerebrospinal fluid samples of pediatric patients over a 10-year period: a retrospective study |
| Q90322380 | Process optimization for the rapid production of Enterovirus 71 |
| Q26866091 | Production of EV71 vaccine candidates |
| Q49970753 | Profiling of novel microRNAs elicited by EV71 and CA16 infection in human bronchial epithelial cells using high-throughput sequencing |
| Q37530094 | Progress on the research and development of inactivated EV71 whole-virus vaccines |
| Q47555171 | Prohibitin plays a critical role in Enterovirus 71 neuropathogenesis |
| Q38248866 | Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases |
| Q34358402 | Protection against enterovirus 71 with neutralizing epitope incorporation within adenovirus type 3 hexon |
| Q47560144 | Pulmonary edema following central nervous system lesions induced by a non- mouse-adapted EV71 strain in neonatal BALB/c mice |
| Q36506787 | Quantification of the dynamics of enterovirus 71 infection by experimental-mathematical investigation |
| Q49543280 | Quantifying the influence of temperature on hand, foot and mouth disease incidence in Wuhan, Central China |
| Q36383904 | RNA polymerase I-driven reverse genetics system for enterovirus 71 and its implications for vaccine production |
| Q53830457 | Rapid Resolution of Enterovirus 71-Associated Opsoclonus Myoclonus Syndrome on Intravenous Immunoglobulin. |
| Q90533096 | Recent Progress on Functional Genomics Research of Enterovirus 71 |
| Q26849627 | Recent developments in antiviral agents against enterovirus 71 infection |
| Q38299628 | Recombination among human non-polio enteroviruses: implications for epidemiology and evolution |
| Q42572707 | Recombination of human coxsackievirus B5 in hand, foot, and mouth disease patients, China |
| Q38926606 | Regulation of host responses and viral replication by the mitogen-activated protein kinases in intestinal epithelial cells infected with Enterovirus 71. |
| Q39296151 | Replication kinetics of coxsackievirus A16 in human rhabdomyosarcoma cells |
| Q37058984 | Responding to emerging diseases: reducing the risks through understanding the mechanisms of emergence |
| Q28486246 | Retracted: The Interplays between Autophagy and Apoptosis Induced by Enterovirus 71 |
| Q38263484 | Review of enterovirus 71 vaccines |
| Q37688743 | Rheum emodin inhibits enterovirus 71 viral replication and affects the host cell cycle environment |
| Q39188152 | Risk factors for death in children with severe hand, foot, and mouth disease in Hunan, China |
| Q36100122 | Risk of Nephrotic Syndrome following Enteroviral Infection in Children: A Nationwide Retrospective Cohort Study |
| Q40592321 | Risk of leukaemia in children infected with enterovirus: a nationwide, retrospective, population-based, Taiwanese-registry, cohort study |
| Q39150152 | Robust antiviral responses to enterovirus 71 infection in human intestinal epithelial cells |
| Q35957814 | Routine Pediatric Enterovirus 71 Vaccination in China: a Cost-Effectiveness Analysis |
| Q37545731 | SIRT1 inhibits EV71 genome replication and RNA translation by interfering with the viral polymerase and 5'UTR RNA |
| Q38474516 | Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: a randomized, placebo-controlled, double-blind, Phase I clinical trial |
| Q90437647 | Scavenger receptor class a, member 3 is associated with severity of hand, foot, and mouth disease in a case-control study |
| Q48047856 | Selection and characterisation of guanidine-resistant mutants of human enterovirus 71. |
| Q82811412 | Selection and characterization of vaccine strain for Enterovirus 71 vaccine development |
| Q34820250 | Seroepidemiology of human enterovirus71 and coxsackievirusA16 among children in Guangdong province, China |
| Q36479953 | Seroprevalence of Enterovirus 71 Antibody Among Children in China: A Systematic Review and Meta-analysis. |
| Q35063743 | Seroprevalence of human enterovirus 71 and coxsackievirus A16 in Guangdong, China, in pre- and post-2010 HFMD epidemic period |
| Q36742388 | Serum cholinesterase: a potential assistant biomarker for hand, foot, and mouth disease caused by enterovirus 71 infection |
| Q42224514 | Serum cytokine profiles of children with human enterovirus 71-associated hand, foot, and mouth disease |
| Q59800796 | Severe enterovirus A71 associated hand, foot and mouth disease, Vietnam, 2018: preliminary report of an impending outbreak |
| Q59792145 | Severity of enterovirus A71 infection in a human SCARB2 knock-in mouse model is dependent on infectious strain and route |
| Q45978685 | Simple and rapid detection of human enterovirus 71 by reverse-transcription and loop-mediated isothermal amplification: cryopreservation affected the detection ability. |
| Q52716556 | Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff. |
| Q36281127 | Single Neutralizing Monoclonal Antibodies Targeting the VP1 GH Loop of Enterovirus 71 Inhibit both Virus Attachment and Internalization during Viral Entry |
| Q38986465 | Socioeconomic burden of hand, foot and mouth disease in children in Shanghai, China |
| Q59790233 | Space-time heterogeneity of hand, foot and mouth disease in children and its potential driving factors in Henan, China |
| Q34599779 | Spatial-temporal clusters and risk factors of hand, foot, and mouth disease at the district level in Guangdong Province, China |
| Q37473748 | Spatio-temporal analysis on enterovirus cases through integrated surveillance in Taiwan |
| Q35088457 | Spatio-temporal clustering of hand, foot, and mouth disease at the county level in Guangxi, China |
| Q35904090 | Spatiotemporal Cluster Patterns of Hand, Foot, and Mouth Disease at the County Level in Mainland China, 2008-2012. |
| Q40855930 | Status of research and development of vaccines for enterovirus 71. |
| Q47600312 | Structure, Immunogenicity, and Protective Mechanism of an Engineered Enterovirus 71-Like Particle Vaccine Mimicking 80S Empty Capsid |
| Q27677960 | Structures of the Procapsid and Mature Virion of Enterovirus 71 Strain 1095 |
| Q31149613 | Study on risk factors for severe hand, foot and mouth disease in China |
| Q47153408 | Surveillance and laboratory detection for non-polio enteroviruses in the European Union/European Economic Area, 2016. |
| Q61445290 | Surveillance for severe hand, foot, and mouth disease from 2009 to 2015 in Jiangsu province: epidemiology, etiology, and disease burden |
| Q42230193 | Surveillance of hand, foot, and mouth disease for a vaccine |
| Q37401695 | Susceptibilities of enterovirus D68, enterovirus 71, and rhinovirus 87 strains to various antiviral compounds |
| Q38776087 | Susceptibility of human tonsillar epithelial cells to enterovirus 71 with normal cytokine response |
| Q35126871 | Synthesis of novel purine-based coxsackievirus inhibitors bearing polycylic substituents at the N-9 position |
| Q35007304 | TLR3 signaling in macrophages is indispensable for the protective immunity of invariant natural killer T cells against enterovirus 71 infection |
| Q33747338 | The Antibody-Secreting Cell Response to Infection: Kinetics and Clinical Applications |
| Q28066400 | The Current Status of the Disease Caused by Enterovirus 71 Infections: Epidemiology, Pathogenesis, Molecular Epidemiology, and Vaccine Development |
| Q36453732 | The Effects of Weather Factors on Hand, Foot and Mouth Disease in Beijing. |
| Q37458096 | The Epidemiology of Hand, Foot and Mouth Disease in Asia: A Systematic Review and Analysis. |
| Q36311733 | The Golgi protein ACBD3 facilitates Enterovirus 71 replication by interacting with 3A |
| Q89492277 | The RNA-dependent RNA polymerase of enterovirus A71 associates with ribosomal proteins and positively regulates protein translation |
| Q35693536 | The Role of VP1 Amino Acid Residue 145 of Enterovirus 71 in Viral Fitness and Pathogenesis in a Cynomolgus Monkey Model |
| Q28550039 | The Suramin Derivative NF449 Interacts with the 5-fold Vertex of the Enterovirus A71 Capsid to Prevent Virus Attachment to PSGL-1 and Heparan Sulfate |
| Q34289956 | The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection-suramin inhibits EV71 infection in vitro and in vivo |
| Q35826072 | The association of recombination events in the founding and emergence of subgenogroup evolutionary lineages of human enterovirus 71 |
| Q36389012 | The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals |
| Q34048432 | The correlation between the presence of viremia and clinical severity in patients with enterovirus 71 infection: a multi-center cohort study |
| Q35048558 | The cross-neutralizing activity of enterovirus 71 subgenotype c4 vaccines in healthy chinese infants and children |
| Q92151714 | The epidemic characteristics and spatial autocorrelation analysis of hand, foot and mouth disease from 2010 to 2015 in Shantou, Guangdong, China |
| Q38552679 | The epidemiology of non-polio enteroviruses: recent advances and outstanding questions |
| Q38126917 | The interaction between human enteroviruses and type I IFN signaling pathway. |
| Q90345270 | The interplay of autophagy and enterovirus |
| Q37716692 | The molecule of DC-SIGN captures enterovirus 71 and confers dendritic cell-mediated viral trans-infection |
| Q89790315 | The pyrimidine analog FNC potently inhibits the replication of multiple enteroviruses |
| Q87623868 | The risk factors of hand-foot-mouth disease in Chinese Mainland people |
| Q35154777 | The role of Misshapen NCK-related kinase (MINK), a novel Ste20 family kinase, in the IRES-mediated protein translation of human enterovirus 71. |
| Q100500929 | The transfer and decay of maternal antibodies against enterovirus A71, and dynamics of antibodies due to later natural infections in Chinese infants: a longitudinal, paired mother-neonate cohort study |
| Q37886179 | The virology and developments toward control of human enterovirus 71. |
| Q28080796 | Therapeutic and prevention strategies against human enterovirus 71 infection |
| Q35145386 | Therapeutic effect of Jinzhen oral liquid for hand foot and mouth disease: a randomized, multi-center, double-blind, placebo-controlled trial |
| Q34261565 | Toll-like receptor 9-mediated protection of enterovirus 71 infection in mice is due to the release of danger-associated molecular patterns |
| Q36974365 | Transmission of Hand, Foot and Mouth Disease and Its Potential Driving Factors in Hong Kong |
| Q40360408 | Transmission patterns of human enterovirus 71 to, from and among European countries, 2003 to 2013. |
| Q40955592 | Two-year efficacy and immunogenicity of Sinovac Enterovirus 71 vaccine against hand, foot and mouth disease in children |
| Q38732933 | USP19 suppresses cellular type I interferon signaling by targeting TRAF3 for deubiquitination |
| Q58759523 | USP4 positively regulates RLR-induced NF-κB activation by targeting TRAF6 for K48-linked deubiquitination and inhibits enterovirus 71 replication |
| Q38567118 | Understanding Enterovirus 71 Neuropathogenesis and Its Impact on Other Neurotropic Enteroviruses |
| Q38192021 | Update of enterovirus 71 infection: epidemiology, pathogenesis and vaccine |
| Q38225695 | Update on the development of enterovirus 71 vaccines |
| Q58786286 | Using Baidu index to nowcast hand-foot-mouth disease in China: a meta learning approach |
| Q90312100 | Using Statistical Phylogenetics for Investigation of Enterovirus 71 Genotype A Reintroduction into Circulation |
| Q59360173 | VP1 amino acid residue 145 of enterovirus 71 is a key residue for its receptor attachment and resistance to neutralizing antibody during cynomolgus monkey infection |
| Q39162997 | VP1 residues around the five-fold axis of enterovirus A71 mediate heparan sulfate interaction |
| Q37130739 | Validation and evaluation of serological correlates of protection for inactivated enterovirus 71 vaccine in children aged 6-35 months |
| Q35730704 | Validation and utilization of an internally controlled multiplex Real-time RT-PCR assay for simultaneous detection of enteroviruses and enterovirus A71 associated with hand foot and mouth disease |
| Q42230006 | Variations in cerebrospinal fluid viral loads among enterovirus genotypes in patients hospitalized with laboratory-confirmed meningitis due to enterovirus |
| Q40627065 | Vesicular stomatitis virus-based vaccines expressing EV71 virus-like particles elicit strong immune responses and protect newborn mice from lethal challenges |
| Q61813261 | Viperin Inhibits Enterovirus A71 Replication by Interacting with Viral 2C Protein |
| Q37688138 | Viral Aetiology of Acute Flaccid Paralysis Surveillance Cases, before and after Vaccine Policy Change from Oral Polio Vaccine to Inactivated Polio Vaccine |
| Q37996089 | Viral and host factors that contribute to pathogenicity of enterovirus 71. |
| Q36825383 | Virus infections in the nervous system |
| Q44201038 | Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice. |
| Q42265420 | Virus-like particles produced in Saccharomyces cerevisiae elicit protective immunity against Coxsackievirus A16 in mice |
| Q34844126 | Workshop on use of intravenous immunoglobulin in hand, foot and mouth disease in Southeast Asia |
Search more.